Delivery Order SPE2DB22D2007-SPE2DB25FJ0CY

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,574.46 and a completion date of September 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $3,034.80 and a completion date of March 27, 2025. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has a firm fixed price of $2,797.75 and a period of performance through March 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide M-M-R II vaccine vials. The contract has a ceiling value of $11,077.80 and runs through March 10, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $14,510.94 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.57 firm fixed-price contract is for the procurement of M-M-R II vaccine vials, with a period of performance through December 31, 2024. The contract is not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,084.38 firm-fixed-price contract is for the delivery of M-M-R II vaccine vials, with a completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $86,445.85 and a completion date of September 3, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of M-M-R II vaccine vials, with a firm fixed price ceiling value of $1,175.56 and a performance period through April 2, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of M-M-R II vaccine vials. The delivery order, valued at $3,165.80, was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0CY
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $29,360.13 and a period of performance through March 25, 2025. It is a firm-fixed-price contract type with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order falls under this broader IDC mechanism, enabling efficient government procurement of critical medical commodities including vaccines to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/29/25, 12:55 AM